New trends in the treatment of orthostatic hypotension

Current Hypertension Reports

Volumn 3, Issue 3, 2001, Pages 216-224

  Jordan, Jens ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; ORTHOSTATIC HYPOTENSION; REVIEW; THERAPY;

HUMANS; HYPOTENSION, ORTHOSTATIC; THERAPEUTICS;

EID: 0035375120     PISSN: 15226417     EISSN: 15343111     Source Type: Journal    
DOI: 10.1007/s11906-001-0041-7     Document Type: Article

References (57)

1. Robertson D: Treatment of cardiovascular disorders: orthostatic hypotension. In Clinical Pharmacology Basic Principles in Therapeutics. Edited by Melmon KL, Morrelli HF. New York: McGraw-Hill; 1992:84-103.
2. Onrot J, Goldberg MR, Hollister A.S., et al.: Management of chronic orthostatic hypotension. Am J Med 1986, 80:454-464.
3. Biaggioni I, Robertson RM, Robertson D: Manipulation of norepinephrine metabolism with yohimbine in the treatment of autonomic failure. J Clin Pharmacol 1994, 34:418-423.
4. Shannon JR, Jordan J, Diedrich A., et al.: Sympathetically mediated hypertension in autonomic failure. Circulation 2000, 101: 2710-2715.
5. Jordan J, Shannon JR, Grogan E, et al: A potent pressor response elicited by drinking water. Lancet 1999, 353:723.
6. Jordan J, Shannon JR, Black BK, et al.: The pressor response to water drinking in humans: a sympathetic reflex? Circulation 2000, 101: 504-509.
7. Sato T, Kawada T, Shishido T, et al.: Novel therapeutic strategy against central baroreflex failure: a bionic baroreflex system. Circulation 1999, 100:299-304.
8. Jacob G, Ertl AC, Shannon JR, et al.: Effect of standing on neurohormonal responses and plasma volume in healthy subjects. J Appl Physiol 1998, 84:914-921.
9. Youmans JB, Wells HS, Donley D, Miller DG: The effect of posture (standing) on the serum protein concentration and colloid osmotic pressure of blood. J Clin Invest 1934, 13:447-459.
10. Jacobsen TN, Morgan BJ, Scherrer U, et al: Relative contributions of cardiopulmonary and sinoaortic baroreflexes in causing sympathetic activation in the human skeletal muscle circulation during orthostatic stress. Circ Res 1993, 73:367-378.
11. Smit AA, Halliwill JR, Low P.A., Wieling W: Pathophysiological basis of orthostatic hypotension in autonomic failure. J Physiol Lond 1999, 519 Pt 1:1-10.
12. Bradbury S, Eggleston C: Postural hypotension: a report of three cases. Am Heart J 1925, 1:73-86.
13. Robertson D, Hollister AS, Biaggioni I, et al: The diagnosis and treatment of baroreflex failure. N Engl J Med 1993, 329:1449-1455.
14. Jordan J, Shannon JR, Black B, et al: Malignant vagotonia due to selective baroreflex failure. Hypertension 1997, 30:1072-1077.
15. Wenning GK, Tison F, Ben S.Y., et al.: Multiple system atrophy: a review of 203 pathologically proven cases. Move Disord 1997, 12:133-147.
16. Kanda T, Tomimitsu H, Yokota T., et al.: Unmyelinated nerve fibers in sural nerve in pure autonomic failure. Ann Neurol 1998, 43:267-271.
17. Robertson D, Goldberg MR, Onrot J, et al: Isolated failure of autonomic noradrenergic neurotransmission: evidence of impaired b-hydroxylation of dopamine. N Engl J Med 1986, 314:1494-1497.
18. Gaan D, Mahoney MP, Rowlands D.J., Jones AW: Postural hypotension in amyloid disease. Am Heart J 1972, 84:395-400.
19. Lagi A, Bacalli S, Cencetti S., et al.: Cerebral autoregulation in orthostatic hypotension. A transcranial Doppler study. Stroke 1994, 25:1771-1775.
20. Wilcox CS, Aminoff MJ, Penn W: Basis of nocturnal polyuria in patients with autonomic failure. J Neurol Neurosurg Psychiatry 1974, 37:677-684.
21. Jordan J, Shannon JR, Pohar B, et al: Contrasting effects of vasodilators on blood pressure and sodium balance in the hypertension of autonomic failure. J Am Soc Nephrol 1999, 10: 35-42.
22. Kaufmann H, Oribe E, Pierotti A.R., et al.: Atrial natriuretic factor in human autonomic failure. Neurology 1990, 40:1115-1119.
23. Wilcox CS, Aminoff MJ, Slater JD: Sodium homeostasis in patients with autonomic failure. Clin Sci Mol Med 1977, 53:321-328.
24. Robertson D, Kincaid DW, Haile V, Robertson RM: The head and neck discomfort of autonomic failure: an unrecognized aetiology of headache. Clin Autonom Res 1994, 4:99-103.
25. Vagaonescu TD, Saadia D, Tuhrim S., et al.: Hypertensive cardiovascular damage in patients with primary autonomic failure. Lancet 2000, 355:725-726.
26. Jordan J, Shannon JR, Biaggioni I, et al.: Contrasting actions of pressor agents in severe autonomic failure. Am J Med 1998, 105: 116-124.
27. Masaki KH, Schatz I, Burchfield CM, et al.: Orthostatic hypotension predicts mortality in elderly men: the Honolulu Heart Program. Circulation 1998, 98:2290-2295.
28. Fouad-Tarazi F.M., Okabe M, Goren H: Alpha sympathomimetic treatment of autonomic insufficiency with orthostatic hypotension. Am J Med 1995, 99:604-610.
29. Low PA, Gilden JL, Freeman R, et al: Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study. Midodrine Study Group. JAMA 1997, 277:1046-1051.
30. Smit AA, Wieling W, Opfer GT, et al.: Patients' choice of portable folding chairs to reduce symptoms of orthostatic hypotension. Clin Auton Res 1999, 9:341-344.
31. Denq JC, Opfer GT, Giuliani M, et al: Efficacy of compression of different capacitance beds in the amelioration of orthostatic hypotension. Clin Auton Res 1997, 7:321-326.
32. Shear L: Orthostatic hypotension. Treatment with sodium chloride and sodium retaining steroid hormones. Arch Intern Med 1968, 122:467-471.
33. Hickler RB, Thompson GR, Fox L.M., Hamlin JT: Successful treatment of orthostatic hypotension with 9-alpha-fluorohy-drocortisone. N Engl J Med 1959, 261:788-791.
34. Davidson C, Smith D, Morgan DB: Diurnal pattern of water and electrolyte excretion and body weight in idiopathic orthostatic hypotension. The effect of three treatments. Am J Med 1976, 61: 709-715.
35. Mitsky VP, Workman RJ, Nicholson W.E., et al.: A sensitive radioimmunoassay for fludrocortisone in human plasma. Steroids 1994, 59:555-558.
36. Chobanian AV, Volicer L, Tifft C.P., et al.: Mineralocorticoid-induced hypertension in patients with orthostatic hypotension. N Engl J Med 1979, 301:68-73.
37. Bannister R, Ardill L, Fentem P: An assessment of various methods of treatment of idiopathic orthostatic hypotension. QJ Med 1969, 38:377-395.
38. Shannon JR, Jordan J, Costa F., et al.: The hypertension of autonomic failure and its treatment. Hypertension 1997, 30:1062-1067.
39. Biaggioni I, Onrot J, Stewart C.K., Robertson D: The potent pressor effect of phenylpropanolamine in patients with autonomic impairment. JAMA 1987, 258:236-239.
40. Robertson D, Hollister AS, Carey E.L., et al.: Increased vascular beta2-adrenoreceptor responsiveness in autonomic dysfunction. J Am Coll Cardiol 1984, 3:850-856.
41. Davies B, Sudera D, Sagnella G., et al.: Increased numbers of alpha receptors in sympathetic denervation supersensitivity in man. J Clin Invest 1982, 69:779-784.
42. Mohring J, Glanzer K, Maciel J.J., et al.: Greatly enhanced pressor response to antidiuretic hormone in patients with impaired cardiovascular reflexes due to idiopathic orthostatic hypotension. J Cardiovasc Pharmacol 1980, 2:367-376.
43. Page IH, McCubbin JW: Buffer reflexes, tolerance to ganglioplegics and their relationship to enhanced pressor responsiveness. Am J Physiol 1959, 197:217-222.
44. Haas E, Goldblatt H: Effects of various ganglionic blocking agents on blood pressure and on activity of pressor agents. J Physiol 1960, 198:1023-1028.
45. Shannon JR, Jordan J, Black B., et al.: Uncoupling of the baroreflex by NN-cholinergic blockade in dissecting the components of cardiovascular regulation. Hypertension 1998, 101-107.
46. Robertson D: Contraindication to the use of ocular phenylephrine in idiopathic orthostatic hypotension. Am J Ophthalmol 1979, 87:819-822.
47. Wilkinson GR, Beckett AH: Absorption, metabolism and excretion of the ephedrines in man. I. The influence of urinary pH and urine volume output. J Pharm Exp Ther 1968, 162:139-147.
48. Sever PS, Dring LG, Williams RT: The metabolism of (-)-ephedrine in man. Eur J Clin Pharmacol 1975, 9:193-198.
49. FDA: Food Advisory Committee meeting. Clinical summaries of adverse event reports on dietary supplements that may contain ephedrine alkaloids. Docket No. 95N-0304; 1996:1-125.
50. Crook JE, Robertson D, Whorton AR: Prostaglandin suppression: inability to correct severe idiopathic orthostatic hypotension. South Med J 1981, 74:318-320.
51. Abate G, Polimeni RM, Cuccurullo F, et al: Effects of indomethacin on postural hypotension in Parkinsonism. BMJ 1979, 2:1466-1468.
52. Kochar MS, Itskovitz HD: Treatment of idiopathic orthostatic hypotension (Shy-Drager syndrome) with indomethacin. Lancet 1978, 1:1011-1014.
53. Goldberg MR, Robertson D, FitzGerald GA: Prostacyclin biosynthesis and platelet function in autonomic dysfunction. Neurology 1985, 35:120-123.
54. Davies IB, Bannister R, Hensby C., Sever PS: The pressor actions of noradrenaline and angiotension II in chronic autonomic failure treated with indomethacin. Br J Clin Pharmacol 1980, 10: 223-229.
55. Onrot J, Goldberg MR, Biaggioni I, et al: Hemodynamic and humoral effects of caffeine in autonomic failure. Therapeutic implications for postprandial hypotension. N Engl J Med 1985, 313:549-554.
56. Onrot J, Goldberg MR, Biaggioni I, et al: Oral yohimbine in human autonomic failure. Neurology 1987, 37:215-220.
57. Hoffman WE, Phillips MI, Wilson E, Schmid PG: A pressor response associated with drinking in rats. Proc Soc Exp Biol Med 1977, 154:121-124.